The Human Variable 

Remission is often defined as symptom improvement at a single moment in time. The CYNAERA Remission Standard™ challenges that assumption by introducing a state-dependent model that evaluates stability, durability, function, flare control, and resilience over time. Applied across Long COVID, autoimmune disease, and clinical trials, this framework provides a more accurate way to measure recovery, reduce misclassification, and align outcomes with real-world patient experience.

A field guide for designing Lyme disease clinical trials that work. Learn how to improve outcomes using adaptive design, co-infection stratification, digital biomarkers, and CYNAERA’s stabilization-first framework.

CYNAERA introduces a terrain-responsive , state-dependent CRISPR safety framework for sickle cell disease, integrating AI-driven targeting, timing optimization, and simulation modeling to reduce risk, lower costs, and enable scalable, more accessible gene therapy deployment across complex chronic conditions.

Climate accelerated wildfires, burning over 7.7 million acres in 2020–2021, threaten the 65–75 million Americans with Infection-Associated Chronic Conditions (IACCs), including Long COVID, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Postural Orthostatic Tachycardia Syndrome (POTS), Mast Cell Activation Syndrome (MCAS), and Small Fiber Neuropathy (SFN) If you want an alternate tone that leans slightly more policy-facing:

P.R.O.O.F. GPT™ was developed to support harm-aware analysis in complex systems. P.R.O.O.F. stands for People Revealing Overlooked & Outdated Failures. The system applies the Moral Adinig Method to identify omissions, delays, representation gaps, and outdated assumptions that increase risk exposure. Its purpose is not to assign blame or rank vulnerability, but to improve system reliability and safeguard design.

Infection-associated chronic conditions (IACCs), including Long COVID, ME/CFS, post-treatment Lyme disease syndrome (PTLDS), and related post-infectious syndromes, present a persistent challenge to conventional medical workflows. These conditions are multi-system, fluctuating, and temporally delayed, with symptom expression shaped by environmental exposures, autonomic regulation, immune reactivity, hormonal state, and cumulative demand.